marksans pharma: Live & Latest News Updates : Vimarsana.com

investment strategy: Kenneth Andrade on why he is avoiding banks & financials; betting on power, pharma stocks

Kenneth Andrade anticipates significant growth in the power market, emphasizing massive investments in energy capex equivalent to India's GDP over the next 15 years. He discusses the impact on various sectors and the rationale behind his pharma holdings, focusing on profitability potential. Andrade says he is avoiding banks because he chooses to be on the asset side and not on the liability side.

What drew MIT's investment arm to this small cap pharma company?

MIT's recent investment in Marksans Pharma underscores the small-cap's hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.

Marksans Pharma's Goa unit concludes USFDA inspection with observations

Kolkata-based Suraksha Diagnostic eyes $100 million IPO; PE investor OrbiMed to sell stake

Marksans Pharma Q3 FY24 Results Live: Profit Rises by 31.27% YoY

Marksans Pharma Q3 FY24 Results Live: Revenue increased by 22.15% YoY & profit increased by 31.27% YoY

Betting Big! MFs raise stake in 30 stocks for 3 straight quarters, 11 turn multibaggers

Barring two companies – Balrampur Chini Mills and Shree Cement – rest of the stocks have given atleast double-digit returns so far in the current financial year.

OrbiMed strikes fresh bet on Indian wheelchair manufacturer

Global healthcare-focussed mid-market private equity firm OrbiMed, which counts companies like Advanced Enzymes, Entero Healthcare, Marksans Pharma, Suraksha Clinic, Kapiva, Bharat Serum, and Asian Institute ......

OrbiMed: Arcatron Mobility raise growth capital from OrbiMed, a global healthcare-focused investment firm

Arcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R&D, develop new products, and improve branding and marketing. Arcatron offers mobility assist devices under its flagship brand "Frido" and offers products across leading e-commerce platforms, its website, and over 1,000 stores across India.

US healthcare investment major invests in Indian mobility assist devices maker Frido

OrbiMed, a global healthcare-focused investment firm along with existing investors BL Taparia Family Office, Chona Family Office, MGA Ventures and founders of Arcatron participated in the funding round

Stock Market Live Updates: Sensex and Nifty open positive on upbeat economic indicators